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CASE REPORT

Unusual Case of Progressive Multifocal Leukoencephalopathy
in a Patient With Sjögren Syndrome
Ifeoma Ndidi Onwubiko, MD, MPH, Kanika Taneja, MD, Nilesh Gupta, MD, and Abir Mukherjee, MD

Abstract: Progressive multifocal leukoencephalopathy (PML) is a rare
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demyelinating disease caused by reactivation of John Cunningham virus affecting typically subcortical and periventricular white matter of immunocompromised hosts (human immunodeficiency virus infection, hematologic
malignancies). Cerebral hemispheric white matter is most commonly affected
by lytic infections, leading to progressive damage to oligodendrocytes in the
central nervous system. Neuroimaging usually highlights scattered foci of white
matter hypodensity not attributable to contrast enhancement or mass effect. In
contrast, we present an unusual case of PML predominantly affecting cervical
spinal cord and brainstem in an immunocompetent host. This is a rare subset of
PML case that can occur in association with connective tissue disorders
(Sjögren Syndrome in this case), systemic lupus erythematosus being the most
common. Progressive multifocal leukoencephalopathy should be considered in
the differential diagnosis of spinal cord or brainstem lesions, particularly in the
patients with connective tissue disorders.
Key Words: progressive multifocal leukoencephalopathy, Sjögren
syndrome, John Cunningham virus, oligodendrocytes, connective tissue
disorders
(Am J Forensic Med Pathol 2020;00: 00–00)

CASE PRESENTATION
A 65-year-old woman with known history of Sjogren syndrome presented to the emergency department at Henry Ford Hospital, Detroit, MI, with a broken ankle secondary to a 4-month-old
fall. She also reported a 4-week history of vertigo, hemiparesis,
and right-sided weakness. Her medical history was pertinent for
cryptogenic cirrhosis, ascites, obstructive sleep apnea on continuous airway positive pressure, and hypothyroidism on Synthroid.
On examination, she appeared ill, pale, minimally responsive, falling back to sleep quickly after waking. She was obtunded,
oriented to person and date, but not to place. She was minimally
verbally responsive. Her speech was slurred with monosyllabic responses. Her pupils were equal and reactive to light with full
extraocular movements. She appeared to have a right facial droop
with no cough and gag reflex. There was absent and reduced muscle tone in the right extremities and left upper extremity, respectively. Sensation to light touch and pain was intact but the
patient was dysmetric with bilateral Babinski sign. There were diminished breath sounds in bilateral lung bases.
Laboratory test showed high ammonia levels (47 μmol/L),
with abnormal liver enzyme (aspartate transaminase, 56 IU/L), elevated blood urea nitrogen at 37 mg/dL, and normal serum creatinine levels at 1.16 mg/dL.
Cerebrospinal analysis was suggestive of a traumatic tap (red
blood cell count, 89,559; white blood cell count, 104  109/L with
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84% neutrophils; glucose, 71 mmol/L; protein, 183 g/dL with negative cultures and no malignant cells on cytology). Hepatitis C antibody screen was negative. Immunoglobin G antibodies to Sjögren
syndrome–related antigen A and anti–Sjögren syndrome-related
antigen B were positive. Thyroglobulin antibodies and antinuclear
antibodies were elevated. Autoimmune serological tests for other
antibodies, including antineutrophil cytoplasmic antibodies, DNA,
Scl-70, perinuclear antineutrophil cytoplasmic antibodies, rheumatoid factor, and Smith antigen, were negative.
Initial computed tomography of the head without contrast
showed no intracranial abnormality. Multiplanar multisequence
magnetic resonance imaging (MRI) of the brain without contrast
showed no acute process. Magnetic resonance imaging of the
spine without contrast showed T2 signal abnormality involving
the medulla extending into the upper cervical cord to C2 to C3
level with C3 medullary lesions (Fig. 1). Differentials, including
low-grade neoplasm, such as astrocytoma, chronic demyelinating
disease and infection, were considered. Follow-up imaging 3 days
later remained unchanged. Patient continued to clinically deteriorate. She was managed for sepsis, pancytopenia, ventilator dependency, and progressive hepatic decompensation. Eight days later,
she died.
At autopsy, gross examination of the brain revealed unremarkable cerebral hemispheres, midbrain, basal ganglia, cerebellum, pons, medulla and spinal cord. Histological examination
revealed confluent, extensive multifocal white matter lesions in
the medulla. The cervical spinal cord, pons, mid brain, cerebellum,
and basal ganglia were affected to a lesser degree. These lesions were
characterized by pallor, edema, perivascular lymphocytic cuffing,
microglial nodules, influx of activated microglial, and numerous oligodendroglial nuclei with ground glass inclusions (Figs. 2, 3, and 4).
The inclusions were immunoreactive with simian virus-40 (SV-40)
(Figs. 5, 6), highlighted by P53 and MIB-1 immunostains. Other
areas showed moderate hypoxic ischemic changes in the neocortex
and hippocampus. These findings supported a diagnosis of progressive multifocal leukoencephalopathy (PML) with moderate hypoxic
ischemic changes (Figs. 7–14).
Autopsy findings of other organs were consistent with bilateral pleural effusion secondary to acute bronchopneumonia, ascites
secondary to hepatic cirrhotic, splenomegaly, and cardiomegaly.

DISCUSSION
Progressive multifocal leukoencephalopathy is an opportunistic demyelinating disease of the central nervous system caused
by reactivation of the DNA viruses of the polyoma group.1 It is
caused by 1 of 2 polyomavirus, John Cunningham (JC) virus,
named after the first patient whose brain the virus was first isolated from.2 Strains of the JC virus has been isolated in nearly
all of the documented PML cases with rare cases linked to the
nonhuman primate viruses, such as simian vacuolating virus
40.3 The disease predominantly affects immunocompromised
hosts, including people with leukemia, human immunodeficiency
virus-1 infection, lymphomas, and renal transplant.4
www.amjforensicmedicine.com
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FIGURE 3. CD45 immunostain 40 highlighting perivascular
lymphocytes.

FIGURE 1. MRI of the spine without contrast. Arrow shows T2
abnormality involving the medulla extending into the upper
cervical.

Since the isolation of JC virus from the human brain of a patient with PML in the 1970s, JC virus seropositivity has been
demonstrated in approximately 33% to 90% of people, depending
on the study and geographical location.5,6 Although a large number of the population are infected with the virus, people remain
asymptomatic until they develop defective long-standing cellmediated immunity.7 Reports have been made in patients with
chronic meningoencephalitis in a young patient8 with chronic
clinical course9 and in an immunocompetent patient with sepsis.10
The disease was initially recognized as a paraneoplastic condition in patients with hematological malignancies.11,12 Inciting
factors to the development of PML are the possibility of transformation of a large proportion of lymphocytes which become unable to participate in immune responses and therapy-induced
immunodeficiency.

FIGURE 2. Myelin immunostain, luxol fast blue/periodic
acid-Schiff 100 showing patchy myelin loss in the white matter
of the medulla.
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Patient with autoimmune conditions, such as systemic lupus
erythematosus, sarcoidosis, rheumatoid arthritis, and connective
tissue disease, such as Sjogren disease independent of immunotherapy could develop PML due to disease associated lymphopenia. In 1998, Smith et al13 described a syndrome characterized by
T-lymphocytes less than 300/μL or a CD4+ cell count of less than
20% of the total T cells on 2 occasions, in the absence of any defined immunodeficiency of therapy leading to low CD 4+ T-cell
levels. By this definition, Kirtava et al14 reported that 5.2% of
Sjorgren syndrome have CD4+ T-lymphocytopenia. In 2008,
Power et al12 reported a rare case of PML in a patient with
CD4+ T-lymphocytopenia and Sjogren syndrome. The pathophysiology could be attributed to leukocyte sequestration in enlarged spleen arising from portal hypertension from hepatic
cirrhosis leading to patients developing leucopenia. In addition,
hypogammoglobinemia sequel to liver cirrhosis contributes to decreased immunity. Transient failure of cellular immunity as seen
in renal failure, liver cirrhosis, pregnancy, hepatitis C infection,
malnutrition, and neurodegenerative disorder and idiopathic
CD4+-associated lymphopenia increases the risk of opportunistic
infections and PML.15 This association of PML with hepatic cirrhosis was documented by Gheuens et al15 who observed the disease as an underlying condition in seven patients that developed

FIGURE 4. CD 163 100 immunohistochemistry stain highlighting
perivascular monocyte/macrophage.
© 2020 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 5. Hematoxylin and eosin stain 40 highlighting JC virus
inclusions within oligodendroglial nuclei.

FIGURE 8. P53 immunohistochemistry stain 100 highlighting JC
virus inclusions within oligodendroglial nuclei.

FIGURE 6. Hematoxylin and eosin stain 200 highlighting JC virus
inclusions within oligodendroglial nuclei.

FIGURE 9. MIB1 immunohistochemistry stain 100 positive in JC
virus inclusions in oligodendroglial nuclei.

FIGURE 7. Simian virus immunochemistry stain 200 highlighting
JC virus inclusions within oligodendroglial nuclei.

FIGURE 10. Oligodendroglial inclusions show no reactivity to
cytomegalovirus immunohistochemistry stain 200.
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FIGURE 11. Oligodendroglial inclusions show no reactivity to
herpes simplex virus 1 immunohistochemistry stain 200.

FIGURE 13. CD3 immunostain 40 showing predominant
perivascular T lymphocytic cuffing in comparison to B
lymphocytes in Figure 14.

PML in her study. It is our assumption that our patient's chronic
lymphopenia might have developed from her underlying connective tissue disease, worsened by cryptogenic hepatic cirrhosis.
Other connective tissue disorders in conjunction with immunotherapy has been associated with PML. In 2005, Clifford et al16
reported three cases of PML in multiple sclerosis (MS) patients
treated with natalizumab. Subsequently, more reports have been
made implicating another immunomodulator fingolimod,17 used
in the treatment of MS patients as well as dimethyl fumarate used
in to treat psoriasis and MS patients.18 Other immunomodulatory
agents, such as rituximab, glucocorticoids, methotrexate, cyclophosphamide, chlorambucil, and azathioprine, have been associated with PML.
Clinical presentation of PML varies in severity from asymptomatic to lethal.19 Patients with PML typically present with subacutely evolving clinical features suggestive of a multifocal
process. These include motor deficits, cognitive decline, sensory
deficits, visual loss, gait disturbances, aphasia, hemianopia, and
difficulties with coordination. Other symptoms include seizures,
which may result from virus-induced demyelination and inflammation of the cerebral cortex. Similar to our case with a rapid clinical course, Kastrup et al20 reported a case of PML of the

FIGURE 12. Oligodendroglial inclusions show no reactivity to
herpes simplex virus 2 immunohistochemistry stain 200.
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brainstem in an immunocompetent patient, however, with a possible JC and BK polyoma virus coinfection.
Neuroimaging usually highlights the scattered foci of white
matter hypodensity not attributable to contrast enhancement or
mass effect. This is in contrast to our finding on MRI brain, which
only demonstrated some abnormality in the medulla and spinal
cord. The absence of typical neuroimaging finding could be attributed to the fact that imaging might have been taken during the
early course of the rapidly progressive PML. In addition, since
our patient's brain tissue stained positive to SV-40, there is a possibility that the meningoencephalitis experienced by our patient
might have been caused by this virus, which typically affects the
cerebral gray matter without demyelination.21
Although the cerebral hemispheric white matter is most commonly affected by lytic infection, leading to progressive damage
to oligodendrocytes in the central nervous system, any level of
the central neuraxis may be involved with rare involvement of
the cerebellum and spinal cord. In contrast, our index patient
had scattered lesions involving the cervical spinal cord and
cerebellum.
Our histological findings of edema, perivascular lymphocytic cuffing, microglial nodules, influx of activated microglial,

FIGURE 14. CD20 immunostain 40 showing few perivascular B
lymphocytic cuffing in comparison to T lymphocytes in Figure 13.
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and numerous oligodendroglial nuclei with ground glass inclusions found on autopsy were consistent with documented findings
for PML. To the best of our knowledge, only 2 SV-40 cases have been
isolated from brains of patients with PML.22 Although inoculation of
the SV-40 virus in monkeys has produced similar histologic findings
consistent with PML in humans, meningoencephalitis related to
SV-40 may very well be a distinct disease entity.
Our study has some limitations. Because PML was not considered in the patient's differential, CD4+ T-lymphocyte count, human immunodeficiency virus, JC virus antibody serology were
not obtained. No molecular detection by polymerase chain reaction, the recognized sensitive and specific method for detecting
human polyomaviruses in clinical samples was performed. The
possibility of a virus other than SV-40, but related to SV-40 family
or group of viruses cannot be ruled out. Neuroimaging findings
and immunohistochemistry positivity to SV-40 is suggestive of
the possibility of isolating a virus related to SV-40 in our patient,
had this investigation been performed antemortem.

SUMMARY
In this report, we described an unusual presentation of PML
occurring in a 65-year-old woman with Sjogren syndrome in
which oligodendroglial cells harbored SV-40–positive inclusions.
This case highlights that although PML has been documented in
immunocompromised patients, it has rarely been associated with
Sjögren syndrome. Awareness of this entity is crucial for pathologists, as well as physicians, to consider as a differential diagnosis
of white matter lesions, irrespective of the sites of neuraxial
involvement.
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